“…Research across several diagnostic groups suggest pharmacotherapy may modify regional brain activity and volume (Arce et al, 2008; Bell et al, 2005; Foland et al, 2008b; Greicius et al, 2008; Hollander et al, 2008; Kohno et al, 2007; Moresco et al, 2001). Although it is possible medication may have contributed to these findings, previous observations that pharmacotherapy can reduce vPFC and amygdala abnormalities in mood disorders suggest inclusion of medicated subjects might have reduced group differences (Anand et al, 2007; Anand et al, 2005; Blumberg et al, 2005; Chen et al, 2008; Dougherty and Rauch, 2007; Jogia et al, 2008; Lawrence et al, 2004; Ozerdem et al, 2008; Yurgelun-Todd et al, 2000).…”